These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27374072)

  • 1. Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA.
    Hall W; Lynskey M
    Lancet Psychiatry; 2016 Sep; 3(9):900-6. PubMed ID: 27374072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA.
    Chiu V; Leung J; Hall W; Stjepanović D; Degenhardt L
    Neuropharmacology; 2021 Aug; 193():108610. PubMed ID: 34010617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis legalisation: should doctors be concerned?
    Kanniah G; Kumar S
    N Z Med J; 2021 Jun; 134(1537):84-90. PubMed ID: 34239164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical framework for regulating for-profit recreational marijuana in US States: Lessons from Colorado and Washington.
    Carnevale JT; Kagan R; Murphy PJ; Esrick J
    Int J Drug Policy; 2017 Apr; 42():71-85. PubMed ID: 28366598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
    Hall W; Stjepanović D; Caulkins J; Lynskey M; Leung J; Campbell G; Degenhardt L
    Lancet; 2019 Oct; 394(10208):1580-1590. PubMed ID: 31657733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "not-for-profit" regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand.
    Wilkins C
    Int J Drug Policy; 2018 Mar; 53():115-122. PubMed ID: 29346087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis Retail Market Indicators in Five Legal States in the United States: A Public Health Perspective.
    Dilley JA; Johnson JK; Colby AM; Sheehy TJ; Muse EJ; Filley JR; Segawa MB; Schauer GL; Kilmer B
    Clin Ther; 2023 Aug; 45(8):778-786. PubMed ID: 37455228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy designs for cannabis legalization: starting with the eight Ps.
    Kilmer B
    Am J Drug Alcohol Abuse; 2014 Jul; 40(4):259-61. PubMed ID: 24853283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reefer madness or much ado about nothing? Cannabis legalization outcomes among young adults in the United States.
    Parnes JE; Smith JK; Conner BT
    Int J Drug Policy; 2018 Jun; 56():116-120. PubMed ID: 29626630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts.
    Hajizadeh M
    Int J Health Policy Manag; 2016 Aug; 5(8):453-456. PubMed ID: 27694657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Has Legal Recreational Cannabis Affected Adolescents in Your State? A Window of Opportunity.
    Feldstein Ewing SW; Lovejoy TI; Choo EK
    Am J Public Health; 2017 Feb; 107(2):246-247. PubMed ID: 28075636
    [No Abstract]   [Full Text] [Related]  

  • 14. How four U.S. states are regulating recreational marijuana edibles.
    Gourdet C; Giombi KC; Kosa K; Wiley J; Cates S
    Int J Drug Policy; 2017 May; 43():83-90. PubMed ID: 28343113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social and public health implications of the legalisation of recreational cannabis: A literature review.
    Mokwena K
    Afr J Prim Health Care Fam Med; 2019 Nov; 11(1):e1-e6. PubMed ID: 31793317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over and under-regulation in the Colorado Cannabis industry - A data-analytic perspective.
    Yates D; Speer J
    Int J Drug Policy; 2018 Sep; 59():63-66. PubMed ID: 30015248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada.
    Lake S; Kerr T; Werb D; Haines-Saah R; Fischer B; Thomas G; Walsh Z; Ware MA; Wood E; Milloy MJ
    Drug Alcohol Rev; 2019 Sep; 38(6):606-621. PubMed ID: 31577059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis legalization with strict regulation, the overall superior policy option for public health.
    Rehm J; Fischer B
    Clin Pharmacol Ther; 2015 Jun; 97(6):541-4. PubMed ID: 25677377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of licensed cannabis businesses in relation to area deprivation in Washington state: A spatiotemporal analysis of cannabis business presence between 2014 and 2017.
    Amiri S; Monsivais P; McDonell MG; Amram O
    Drug Alcohol Rev; 2019 Nov; 38(7):790-797. PubMed ID: 31647158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.